Document Detail


Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
MedLine Citation:
PMID:  21999454     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is considerable biologic plausibility to the hypothesis that genetic variability in pathways involved in insulin signaling and energy homeostasis may modulate dietary risk associated with colorectal cancer. We utilized data from 2 population-based case-control studies of colon (n = 1,574 cases, 1,970 controls) and rectal (n = 791 cases, 999 controls) cancer to evaluate genetic variation in candidate SNPs identified from 9 genes in a candidate pathway: PDK1, RP6KA1, RPS6KA2, RPS6KB1, RPS6KB2, PTEN, FRAP1 (mTOR), TSC1, TSC2, Akt1, PIK3CA, and PRKAG2 with dietary intake of total energy, carbohydrates, fat, and fiber. We employed SNP, haplotype, and multiple-gene analysis to evaluate associations. PDK1 interacted with dietary fat for both colon and rectal cancer and with dietary carbohydrates for colon cancer. Statistically significant interaction with dietary carbohydrates and rectal cancer was detected by haplotype analysis of PDK1. Evaluation of dietary interactions with multiple genes in this candidate pathway showed several interactions with pairs of genes: Akt1 and PDK1, PDK1 and PTEN, PDK1 and TSC1, and PRKAG2 and PTEN. Analyses show that genetic variation influences risk of colorectal cancer associated with diet and illustrate the importance of evaluating dietary interactions beyond the level of single SNPs or haplotypes when a biologically relevant candidate pathway is examined.
Authors:
Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Bette J Caan; John D Potter; Roger K Wolff
Related Documents :
2971464 - The treatment of onychomycosis with a new form of tioconazole.
16485274 - Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal mode...
21780104 - α1-3/4 fucosylation at asn 241 of β-haptoglobin is a novel marker for colon cancer: a...
22076204 - Intrahepatic splenosis mimicking liver metastasis in a patient with gastric cancer.
19553824 - Genome-wide association studies in bladder cancer: first results and potential relevance.
19622594 - Trends in cancer mortality in the elderly in japan, 1970-2007.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-10-14
Journal Detail:
Title:  Nutrition and cancer     Volume:  63     ISSN:  1532-7914     ISO Abbreviation:  Nutr Cancer     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-18     Completed Date:  2012-03-19     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  7905040     Medline TA:  Nutr Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1226-34     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Utah, Salt Lake City, Utah 84108, USA. marty.slattery@hsc.utah.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AMP-Activated Protein Kinases / genetics,  metabolism
Alleles
Case-Control Studies
Colorectal Neoplasms / genetics*
Diet*
Dietary Carbohydrates / administration & dosage
Dietary Fats / administration & dosage
Energy Intake
Genetic Predisposition to Disease
Genotype
Haplotypes*
Humans
Insulin Resistance / genetics
Minnesota
PTEN Phosphohydrolase / genetics,  metabolism
Phosphatidylinositol 3-Kinases / genetics,  metabolism
Polymorphism, Single Nucleotide*
Protein-Serine-Threonine Kinases / genetics,  metabolism
Proto-Oncogene Proteins c-akt / genetics,  metabolism
Ribosomal Protein S6 Kinases, 70-kDa / genetics,  metabolism
Ribosomal Protein S6 Kinases, 90-kDa / genetics,  metabolism
Signal Transduction
TOR Serine-Threonine Kinases / genetics,  metabolism
Tumor Suppressor Proteins / genetics,  metabolism
Utah
Grant Support
ID/Acronym/Agency:
#N01-PC-67000/PC/NCI NIH HHS; CA48998/CA/NCI NIH HHS; CA61757/CA/NCI NIH HHS; R01 CA048998/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Dietary Carbohydrates; 0/Dietary Fats; 0/Tumor Suppressor Proteins; 0/tuberous sclerosis complex 1 protein; 4JG2LF96VF/tuberous sclerosis complex 2 protein; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.1.1/MTOR protein, human; EC 2.7.1.1/TOR Serine-Threonine Kinases; EC 2.7.1.137/PIK3CA protein, human; EC 2.7.11.1/AMP-Activated Protein Kinases; EC 2.7.11.1/PRKAG2 protein, human; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.1/Ribosomal Protein S6 Kinases, 70-kDa; EC 2.7.11.1/Ribosomal Protein S6 Kinases, 90-kDa; EC 2.7.11.1/ribosomal protein S6 kinase, 70kD, polypeptide 1; EC 2.7.11.1/ribosomal protein S6 kinase, 70kD, polypeptide 2; EC 2.7.11.1/ribosomal protein S6 kinase, 90kDa, polypeptide 3; EC 2.7.11.2/pyruvate dehydrogenase (acetyl-transferring) kinase; EC 3.1.3.48/PTEN protein, human; EC 3.1.3.67/PTEN Phosphohydrolase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of laryngeal mask airway in near-term and term neonates during resuscitation: Is it effective an...
Next Document:  The history of kidney stone dissolution therapy: 50 years of optimism and frustration with renacidin...